Page 495 - O_Desenvolvimento_do_Autismo
P. 495

(eds.). Emotions, cognition and behavior. Cambridge: Cambridge University
                Press, 1984, pp. 366-408.






                CLINICALTRIALS.GOV “Effects of CX-516 on functioning in Fragile X and
                autism”. Study ID Number CORX-CX516-013, 2003.







                COLEMAN, M. e GILBERG, C. The biology of autistic syndromes. 2ª
                edição. Londres: McKeith Press, 1992.






                COMI, A.; ZIMMERMAN, A.; FRYE, V.; LAW, P. e PEEDEN, J. “Familial
                clustering of autoimmune disorders and evaluation of medical risk factors in
                autism”. Journal of Child Neurology 14(6), 1999, pp. 388-394.






                CONIGLIO, S. J.; LEWIS, J. D.; LANG, C.; BURNS, T. G.; SUBHANI-
                SIDDIQUE, R.; WEINTRAUB, A.; SCHUB, H. e HOLDEN, E. W. “A
                randomized double-blind, placebo-controlled trial of single-dose
                intravenous secretin as treatment for children with autism”. Journal of

                Pediatrics 138, 2001, pp. 649-655.






                COOK, D. e DUNN, W. “Sensory integration for students with autism”. In: R.
                Simpson e B. Myles (eds.). Educating children and youth with autism.
                Austin: Pro-Ed, 1998, pp. 191-240.






                COOK, E. H. “Brief report: pathophysiology of autism – neurochemistry”.
                Journal of Autism and Developmental Disorders 26(2), 1996, pp. 221-225.
   490   491   492   493   494   495   496   497   498   499   500